Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση των μηχανισμών σηματοδότησης της θυρεοειδικής ορμόνης στην καρδιά
Abstract
dc:descriptionBesides the well characterized genomic action of thyroid hormone, mediated by its nuclear receptors (TRs), accumulating data support the so called non-genomic action of T3, which is often related to activation of signalling pathways. The aim of the present study was to investigate T3 action on intracellular signalling pathways and on the remodeling of the heart. In order to achieve this goal we used adult cardiac myocytes. Initially, we investigated the activation of signalling pathways by T3. Our results demonstrate that T3 promotes a rapid increase in the phosphorylation of kinases ERK1/2, p38-MAPK, Akt and PKCδ within 5-20 minutes. This activation is inhibited by triiodothyroacetic acid (triac) a T3 analogue known to displace the hormone from membrane bound receptors, indicating that this T3 effect is mediated through a cell membrane initiated mechanism. In addition, we investigated the activation of signaling pathways in H9c2 cells. T3 administration resulted in a rapid phosphorylation of ERK1/2, Akt and PKCα/β in these cells. We further investigated a possible interaction of T3 genomic and non-genomic action. Cardiomyocytes were incubated with specific inhibitors of the T3-activated kinases. The pharmacological inhibition of the these kinases showed that the long-term effects of T3 on sarcoplasmic reticulum Ca2+-ATPase (SERCA) upregulation, α- and β- myosin heavy chain (MHC) gene and protein expression are reverted. These results imply that what is initiated as a non-genomic action of the hormone interfaces with genomic effects and could modulate the expression of target proteins important in cardiac function. Although T3 downregulates the expression of phospholamban (PLB) mRNA, an increase in PLB pentamer protein expression was observed. We show that this increase is due to increased phosphorylation of PLB monomers that lead to increased pentamer formation. From the above we conclude that signal transduction pathways mediate expression of T3-target genes, both on transcriptional and post-transcriptional level. It is well established that T3 has prominent effects on cardiac physiology that could result in compensatory chamber remodeling. We investigated whether T3 can induce hypertrophy directly in cultured cardiac myocytes. The results indicated that T3 induced physiological growth as evidenced by the increased cell size and the unaltered ANP expression, a well known marker of pathological hypertrophy. Inhibition of the T3-activated kinases reversed the effect on cell growth implying the involvement of signalling pathways in this process. We also investigated the action of T3 on the shape of cardiac cells that undergo pathological hypertrophy. T3 changed the shape of these cardiac cells indicating that T3 could reverse pathological hypertrophy to a normal cardiac configuration. We further investigated the effect of DEA and DBD on the transcriptional activity of thyroid hormone receptors, TRα1 and TRβ1. The transcriptional activity of the TRα1 receptor seemed to be specifically decreased by DBD. This inhibitor could be used as a potential therapeutic agent for manipulating T3 actions in the physiology of both heart and the whole organism. In summary, the results of the present study provide insights into the mechanisms of T3 action in adult cardiac myocytes. These can be further used to investigate the pathophysiology of the heart.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Iordanidoy, Anna
- Ιορδανίδου, Άννα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28362